David Kerr: Self obsessing health technology

Has the health tech industry and those who fund it lost the plot? Apparently, the next must have technology is the connected toothbrush. A “data driven oral health startup” company in the United States has just received a multi-million dollar investment to further develop a smartphone connected toothbrush. With this toothbrush, an accelerometer measures how […]

Read More…

The BMJ Today: When the worst choice is no choice at all

You would think that any woman raped as an act of war would be given access to a safe abortion by an international organisation providing aid. Sally Howard’s Feature on thebmj.com reveals that, astonishingly, this is often not the case. I would highly recommend reading this article. It explains that the 1973 Helms Amendment to the […]

Read More…

Jamila Sherif et al: The current state of healthcare in Gaza

State of healthcare in June 2014 Three weeks before the start of the current Israel–Gaza conflict, the Palestinian Ministry of Health in Gaza declared an emergency, saying that they were unable to maintain health services owing to a lack of sufficient electricity and necessary supplies. Elective operations had to be cancelled. Thirty per cent of […]

Read More…

Mary McCarthy: UK GPs versus EU GPs

I sometimes wonder if the UK government realises how much general practices in this country accomplish in comparison to their counterparts in Europe and the United States. There was a time, 20 or 30 years ago, when there was not much to choose between GPs in the UK and family doctors in other countries, apart from […]

Read More…

Liz Wager: Research integrity—how can institutions balance discipline and support?

The suicide of Yoshiki Sasai is both tragic and shocking. Sasai was deputy director of the RIKEN Center for Developmental Biology, and a co-author of reports in Nature on the phenomenon of “stimulus-triggered acquisition of pluripotency” (or STAP), which were retracted. Although Sasai was not accused of misconduct himself, he was criticised in an institutional […]

Read More…

Richard Lehman’s journal review—11 August 2014

NEJM 7 August 2014 Vol 371 497  A new gene for breast cancer susceptibility? The PALB2 gene locus has been known about for several years, but this study puts it firmly on the map by intensively investigating 362 members of 154 affected families. The risk for female PALB2 mutation carriers, as compared with the general […]

Read More…

The BMJ Today: Combating Ebola, and more on statins

This morning the World Health Organization (WHO) has declared the Ebola outbreak in West Africa an international health emergency and stated that a concerted international response is required to stop and reverse the spread of the disease. The Ebola epidemic presents a quandary for the medical community. In the absence of evidence based treatments, should […]

Read More…